KURA ONCOLOGY, INC. Number of Operating Segments
KURA ONCOLOGY, INC. (KURA) reported Number of Operating Segments of 1 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-12
- KURA ONCOLOGY, INC. number of operating segments for the quarter ending 2026-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- KURA ONCOLOGY, INC. number of operating segments for the quarter ending 2025-03-31 was 1.00 Segment.
- KURA ONCOLOGY, INC. number of operating segments for the quarter ending 2015-03-31 was 1.00 Segment.
- KURA ONCOLOGY, INC. number of operating segments for fiscal 2025 was 1.00 Segment, a 0.00% change from fiscal 2024.
- KURA ONCOLOGY, INC. number of operating segments for fiscal 2024 was 1.00 Segment, a 0.00% change from fiscal 2023.
- KURA ONCOLOGY, INC. number of operating segments for fiscal 2023 was 1.00 Segment, a 0.00% change from fiscal 2022.
- KURA ONCOLOGY, INC. number of operating segments for fiscal 2022 was 1.00 Segment, a 0.00% change from fiscal 2021.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 Segment 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | 1.00 Segment 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-03-05 | |||
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | 1.00 Segment 10-Q · filed 2025-05-01 | |||
| 2024-12-31 | 1.00 Segment 10-K · filed 2025-02-28 | |||
| 2023-12-31 | 1.00 Segment 10-K · filed 2024-02-27 | |||
| 2022-12-31 | 1.00 Segment 10-K · filed 2023-02-23 | |||
| 2021-12-31 | 1.00 Segment 10-K · filed 2022-02-24 | |||
| 2020-12-31 | 1.00 Segment 10-K · filed 2021-02-24 | |||
| 2019-12-31 | 1.00 Segment 10-K · filed 2020-02-25 | |||
| 2018-12-31 | 1.00 Segment 10-K · filed 2019-03-05 | |||
| 2017-12-31 | 1.00 Segment 10-K · filed 2018-03-12 | |||
| 2016-12-31 | 1.00 Segment 10-K · filed 2017-03-14 | |||
| 2015-12-31 | 1.00 Segment 10-K · filed 2016-03-17 | |||
| 2015-09-30 | 1.00 Segment 10-Q · filed 2015-11-13 | |||
| 2015-06-30 | 1.00 Segment 10-Q · filed 2015-08-14 | |||
| 2015-03-31 | 1.00 Segment 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |